To include your compound in the COVID-19 Resource Center, submit it here.

Grassley calls for FDA drug safety office

Sen. Chuck Grassley (R-Iowa) called for the establishment of an independent office of drug safety at FDA. Speaking at a Finance Committee hearing on the withdrawal of Merck's Vioxx rofecoxib,

Read the full 302 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE